<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药通社 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-28T01:52:20+08:00</updated>
  <subtitle>医药：政策、资讯、产业、发展</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>CDE《化学仿制药透皮贴剂药学研究技术指导原则（试行）》发布！</title>
    <updated>2020-12-27T23:40:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/0B74DPDiQrg3x0U0sepUEg</id>
    <link href="https://mp.weixin.qq.com/s/0B74DPDiQrg3x0U0sepUEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>生物等效性研究的审评考虑</title>
    <updated>2020-12-27T23:40:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/6kBYhx1m8PoqWn8M9VmExg</id>
    <link href="https://mp.weixin.qq.com/s/6kBYhx1m8PoqWn8M9VmExg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2020-12-27T23:40:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/Vkq7HxwXB6poXidgpv-Mbg</id>
    <link href="https://mp.weixin.qq.com/s/Vkq7HxwXB6poXidgpv-Mbg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【圣诞狂欢】华北地区药物技术峰会在石家庄荣耀启幕！药融云数据企业版正式上线</title>
    <updated>2020-12-26T22:59:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/lU1gy94jhUKoL6ue7u1hww</id>
    <link href="https://mp.weixin.qq.com/s/lU1gy94jhUKoL6ue7u1hww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>省局遴选兼职药品检查员！</title>
    <updated>2020-12-26T22:59:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/bkvz6go4wTVYECb3N-M-ww</id>
    <link href="https://mp.weixin.qq.com/s/bkvz6go4wTVYECb3N-M-ww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NMPA批准多个1类创新药！涉恒瑞、海思科、诺诚健华！</title>
    <updated>2020-12-26T22:59:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/ss_svgT4Adms5GTO93D4qg</id>
    <link href="https://mp.weixin.qq.com/s/ss_svgT4Adms5GTO93D4qg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2020-12-26T22:59:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/6blwlIp0Eub3RdhHPShDeQ</id>
    <link href="https://mp.weixin.qq.com/s/6blwlIp0Eub3RdhHPShDeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>博志研新与Dong-A ST达成战略合作， 正式转型CDMO业务</title>
    <updated>2020-12-25T19:26:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/bWYFt8rYn1a_29TWtidQ0A</id>
    <link href="https://mp.weixin.qq.com/s/bWYFt8rYn1a_29TWtidQ0A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国家药品带量采购正式启动，12月25日开始信息申报</title>
    <updated>2020-12-25T19:26:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/BWCj1_1f-DQk871sh6izUg</id>
    <link href="https://mp.weixin.qq.com/s/BWCj1_1f-DQk871sh6izUg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>原遗传办副主任、中国生物技术发展中心副主任孙燕荣接受调查！</title>
    <updated>2020-12-25T19:26:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/O7Y62J2PZghkS06UfcwdYg</id>
    <link href="https://mp.weixin.qq.com/s/O7Y62J2PZghkS06UfcwdYg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！国家局药审、械审，大湾区分中心来了！继长三角后又一个！</title>
    <updated>2020-12-23T10:11:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/5xm3dGru0nKVR3tPDZc4-A</id>
    <link href="https://mp.weixin.qq.com/s/5xm3dGru0nKVR3tPDZc4-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【演讲预告】长沙都正生物董事长欧阳冬生教授： 高难度制剂BE研究思路及相关案例分析</title>
    <updated>2020-12-23T10:11:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/7LH9bpEJoyYDtGWXR-lBYQ</id>
    <link href="https://mp.weixin.qq.com/s/7LH9bpEJoyYDtGWXR-lBYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新规则发布，首批1882药品挂网，未通过一致性强制低价！处方回扣，直接取消挂网资格！</title>
    <updated>2020-12-23T10:11:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/GOiy98DDTlP120r598MW3w</id>
    <link href="https://mp.weixin.qq.com/s/GOiy98DDTlP120r598MW3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>高难度硝苯地平控释片，扬子江递交上市申请！本月第二家！</title>
    <updated>2020-12-23T10:11:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/lel4epNiX6sxLsKcm3yvxA</id>
    <link href="https://mp.weixin.qq.com/s/lel4epNiX6sxLsKcm3yvxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《控制近视进展药物临床研究技术指导原则》</title>
    <updated>2020-12-23T10:11:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/IYjaZddqNrPqUldmv7kBRQ</id>
    <link href="https://mp.weixin.qq.com/s/IYjaZddqNrPqUldmv7kBRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2020-12-23T10:11:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/IZ8gLEQwkqD28NEpwL9VCA</id>
    <link href="https://mp.weixin.qq.com/s/IZ8gLEQwkqD28NEpwL9VCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚！国家局药品审评检查长三角分中心挂牌了！</title>
    <updated>2020-12-22T10:19:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/RrddRikqrmD8lPc1fVV8XA</id>
    <link href="https://mp.weixin.qq.com/s/RrddRikqrmD8lPc1fVV8XA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021，科研之路，有“懂王”伊诺凯就够了！</title>
    <updated>2020-12-22T10:19:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/n5kXahfCzvXmJAnobxgWpQ</id>
    <link href="https://mp.weixin.qq.com/s/n5kXahfCzvXmJAnobxgWpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>日本、印度药企首吃螃蟹！疫情下：CFDI首次开展进口药品远程非现场检查试点工作</title>
    <updated>2020-12-22T10:19:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/jdQPI_t-RiQdloPqs4f5pQ</id>
    <link href="https://mp.weixin.qq.com/s/jdQPI_t-RiQdloPqs4f5pQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>累计87个参比未通过审议：CDE发布36批、37批参比制剂公示</title>
    <updated>2020-12-22T10:19:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/zEkLq4vXx4_Wt_uQLo2VCQ</id>
    <link href="https://mp.weixin.qq.com/s/zEkLq4vXx4_Wt_uQLo2VCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>